Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Chubb
Federal Trade Commission
Mallinckrodt
US Army

Generated: April 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Crenolanib

« Back to Dashboard

US Patents for Crenolanib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Crenolanib ➤ Try a Free Trial Benzoimidazole derivatives useful as antiproliferative agents Pfizer Inc (New York, NY) ➤ Try a Free Trial
Crenolanib ➤ Try a Free Trial Processes for the preparation of benzoimidazole derivatives Pfizer Inc (New York, NY) ➤ Try a Free Trial
Crenolanib ➤ Try a Free Trial Method of inhibiting constitutively active phosphorylated FLT3 kinase AROG Pharmaceuticals, LLC (Dallas, TX) ➤ Try a Free Trial
Crenolanib ➤ Try a Free Trial Crenolanib for treating FLT3 mutated proliferative disorders AROG PHARMACEUTICALS, INC. (Dallas, TX) ➤ Try a Free Trial
Crenolanib ➤ Try a Free Trial Crenolanib for treating FLT3 mutated proliferative disorders AROG PHARMACEUTICALS, INC. (Dallas, TX) ➤ Try a Free Trial
Crenolanib ➤ Try a Free Trial Method of inhibiting mutant C-kit AROG PHARMACEUTICALS, INC. (Dallas, TX) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Crenolanib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Crenolanib Argentina 041055 2022-08-28 ➤ Try a Free Trial
Crenolanib Austria 445610 2022-08-28 ➤ Try a Free Trial
Crenolanib Australia 2003250499 2022-08-28 ➤ Try a Free Trial
Crenolanib Brazil 0313942 2022-08-28 ➤ Try a Free Trial
Crenolanib Canada 2495577 2022-08-28 ➤ Try a Free Trial
Crenolanib China 1319966 2022-08-28 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Merck
Mallinckrodt
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: